Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease

NCT03065192 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Parkinson's Disease
Parkinson's Disease
Basal Ganglia Disease
Brain Diseases
Central Nervous System Diseases
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Parkinsonian Disorders

Interventions

DRUG: VY-AADC01

Sponsor

Neurocrine Biosciences

Collaborators

[object Object]